Microlife Sustainability Profile
Microlife Corporation, a leading name in the healthcare technology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1981, the company has established itself as a pioneer in the development of innovative medical devices, particularly in the fields of blood pressure monitoring and thermometry. Microlife is renowned for its advanced diagnostic tools, including its clinically validated blood pressure monitors and digital thermometers, which are distinguished by their accuracy and user-friendly design. The company’s commitment to quality and precision has earned it a strong market position, making it a trusted choice among healthcare professionals and consumers alike. With a focus on enhancing health management, Microlife continues to lead the way in providing reliable solutions for everyday health monitoring.
DitchCarbon Score
How does Microlife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Microlife's score of 53 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Microlife, headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is identified as a current subsidiary of Microlife USA Inc., and any relevant emissions data may be inherited from its parent organisation, which is Morgan Stanley, at a cascade level of 9. Despite the lack of specific emissions data, Microlife is engaged in various climate initiatives. However, there are no documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This suggests that while the company may be aware of the importance of addressing climate change, it has not yet formalised specific targets or initiatives to reduce its carbon footprint. In summary, Microlife's current climate commitments and emissions data remain unclear, with no specific figures or reduction targets reported. The company may benefit from establishing measurable goals to enhance its sustainability efforts and align with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 28,098,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 345,738,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 113,349,000 | 00,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Microlife's Industry?
How Carbon Intensive is Microlife's Location?
Microlife's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Microlife has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
